• PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives

    May 17, 2022, 15:36 by
    Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
    Full story
  • Benefits of Stable Isotope Labelling in Biochemistry Research

    May 17, 2022, 15:36 by
    Stable isotope labeling is a powerful technique with promising applications.
    Full story
  • ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development

    May 17, 2022, 15:36 by
    ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
    Full story
  • Elligo Health Research® Partners With Peoples Rx

    May 17, 2022, 15:36 by
    Elligo Health Research and Peoples Rx Partner on Initiative to Help Share More Clinical Research Opportunities
    Full story
  • Genovac further enhances its antibody discovery services with the ENPICOM IGX Platform

    May 17, 2022, 15:36 by
    ENPICOM has announced that Genovac will use its IGX Platform for its antibody discovery workflows.
    Full story
  • Scipio bioscience Announces Its Revolutionary Asteria© Single-cell RNA-seq Kit and Companion Cytonaut© Analysis Software Are Now Commercially Available

    May 17, 2022, 15:36 by
    Scipio bioscience has announced that Asteria©, the latest breakthrough single-cell RNA-sequencing kit, is now commercially available for any researcher worldwide.
    Full story
  • Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

    May 17, 2022, 15:36 by
    Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.
    Full story
  • CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

    May 17, 2022, 15:36 by
    CYTENA has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins.
    Full story
  • Biotium Announces Acquisition of CAT5™ FFPE RNA/DNA Extraction Technology from Cell Data Sciences

    May 17, 2022, 15:36 by
    Biotium is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction.
    Full story
  • RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer

    May 17, 2022, 15:36 by
    RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the enrollment of the first patient into its PREMIER registry, a prospective, real-world evidence clinical outcomes registry for patients with all stages of cancer, at the University of Texas (UT) Southwestern in Dallas.
    Full story
  • Creative Bioarray Provides Expertise in Delivering Comprehensive Pain Models to Support Pain Studies

    May 17, 2022, 15:36 by
    Full story
  • Creative Bioarray Supplies Comprehensive Products to Support The Needs of Cell Culture Applications

    May 17, 2022, 15:36 by
    Full story
  • DDA Platform Delivers Metabolic Stability Services to Accelerate Drug Discovery Procedures

    May 17, 2022, 15:36 by
    Full story
  • Creative Biogene Generates Professional Cell Expression System to Accelerate Bioproduction Stable Cell Line Development

    May 17, 2022, 15:36 by
    Full story
  • Qvirus Platform Optimized Lentivirus Production System for The Efficient design and Development of Lentivirus Vector

    May 17, 2022, 15:36 by
    Full story
  • Microbiosci Develops Strain Selection and Fermentation Services to Accelerate The Development of Microbial Technologies

    May 17, 2022, 15:36 by
    Full story
  • Drugs and alcohol consumption are the main causes of homelessness

    May 17, 2022, 15:33 by
    I have been searching about lately. The type of details here on the forum is excellent and helpful and is going to assist my friends and I in our studies a couple times a week. It seems like all of the members here acquired a significant amount of info about this and other subjects and types of info like wise show it. I am not browsing websites most of the time although when I get an opportunity i'm usually avidly searching for this type of knowledge and things closely related to it. When anyone gets a chance, take a look at my website: [url=https://elpasodisabilitylawyer.com/practice-areas/]ssa attorney in san elizario, tx[/url]
    Full story
  • CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry

    May 17, 2022, 15:33 by
    Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.
    Full story
  • Alfa Chemistry: Polymer Surfactants Have Exceptional Properties

    May 17, 2022, 15:33 by
    With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.
    Full story
  • CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

    May 17, 2022, 15:33 by
    Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.
    Full story
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »